Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where H. Van De Waterbeemd is active.

Publication


Featured researches published by H. Van De Waterbeemd.


Journal of Molecular Graphics | 1986

Similarities of pharmacophoric patterns revealed by the MEP of metoclopramide, molindone and piquindone, a subgroup of dopamine D-2 receptor antagonists

H. Van De Waterbeemd; Pierre-Alain Carrupt; Bernard Testa

Abstract Molecular electrostatic potential (MEP) calculations based on ab initio wave functions have been used to compare three compounds belonging to two distinct chemical series (substituted benzamides (metoclopramide) and indolones (piquindone and molindone)). These compounds have highly similar pharmacological properties at the receptor level (antagonists binding selectively to the dopamine D2 receptor and in a sodium-dependent manner). The MEPs of these compounds show close similarities and form a common pharmacophoric pattern.


Journal of Pharmacy and Pharmacology | 1987

The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analyses

Bernard Testa; N. El Tayar; Pierre-Alain Carrupt; H. Van De Waterbeemd; G. J. Kilpatrick; Peter Jenner; C. D. Marsden

tes of MTX and anti-tumour monoclonal antibodies


Molecular Pharmacology | 1986

The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.

Gavin J. Kilpatrick; N. El Tayar; H. Van De Waterbeemd; P Jenner; Bernard Testa; C. D. Marsden

ddwin et a1 1986). Overall, these and other related studies (Corvalan et d 1987) indicate that modification of drug biodistribudon with monoclonal antibodies and/or tissue specific targeting with complexes formed with hybrid antibodies may be valid approaches to prolongation of drug survival and/or site-specific targeting. The degree of drug loading of monoclonal antibodies, with theoretical of two molecules per molecule with anti-drug antibody and one molecule per molecule of hybrid antibody, might be a limitation, since the amount of antibody required to carry conventional therapeutic doses of drug would be very high. In addition the extent ofextravasation of antibody is much smaller than that of drugs. But, as this study shows, the survival of drug is markedly prolonged simply with the anti-drug antibody, and the additional site targeting effect possible with hybrid antibodies might mean the possible use of greatly reduced doses of drug.


International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes | 1988

Isotope effects on lipophilicity and polarity

J.B. Falconnet; J.L. Brazier; Bernard Testa; Pierre-Alain Carrupt; H. Van De Waterbeemd


Journal of Molecular Graphics | 1986

Three-dimensional and electronic analysis of Na+-dependent antidopaminergic agents: tropapride and zetidoline

Sonia Collin; Daniel P. Vercauteren; G. Evrard; F. Durant; H. Van De Waterbeemd; Pierre-Alain Carrupt; Bernard Testa


ChemInform | 1986

Molecular Electrostatic Potential of Orthopramides: Implications for Their Interaction with the D-2 Dopamine Receptor.

H. Van De Waterbeemd; Pierre-Alain Carrupt; Bernard Testa


ChemInform | 1985

THE ELECTRONIC STRUCTURE OF DOPAMINE. AN AB INITIO ELECTROSTATIC POTENTIAL STUDY OF THE CATECHOL MOIETY

H. Van De Waterbeemd; Pierre-Alain Carrupt; Bernard Testa


ChemInform | 1984

NMR CONFORMATIONAL STUDY OF AMINOALKYLBENZAMIDES, AMINOALKYL-O-ANISAMIDES, AND METOCLOPRAMIDE, A DOPAMINE RECEPTOR ANTAGONIST

L. Anker; J. Lauterwein; H. Van De Waterbeemd; Bernard Testa


ChemInform | 1983

THEORETICAL CONFORMATIONAL STUDIES OF SOME DOPAMINE ANTAGONISTIC BENZAMIDE DRUGS: 3-PYRROLIDYL- AND 4-PIPERIDYL DERIVATIVES

H. Van De Waterbeemd; Bernard Testa


ChemInform | 1983

BASICITY, LIPOPHILICITY, AND LACK OF RECEPTOR INTERACTION OF N-AMINOALKYLBENZAMIDES AND N-AMINOALKYL-O-ANISAMIDES AS MODEL COMPOUNDS OF DOPAMINE ANTAGONISTS

L. Anker; Bernard Testa; H. Van De Waterbeemd; A. Bornand-Crausaz; A. Theodorou; P Jenner; C. D. Marsden

Collaboration


Dive into the H. Van De Waterbeemd's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L. Anker

University of Lausanne

View shared research outputs
Top Co-Authors

Avatar

N. El Tayar

University of Lausanne

View shared research outputs
Top Co-Authors

Avatar

P Jenner

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Durant

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

G. Evrard

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge